ECSP003845A - NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS - Google Patents

NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS

Info

Publication number
ECSP003845A
ECSP003845A ECSP003845A ECSP003845A EC SP003845 A ECSP003845 A EC SP003845A EC SP003845 A ECSP003845 A EC SP003845A EC SP003845 A ECSP003845 A EC SP003845A
Authority
EC
Ecuador
Prior art keywords
diseases
compounds
pharmaceutically acceptable
angina pectoris
catepsin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Sabine Wallbaum
Tobias Gabriel
Michael Pech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003845 priority Critical patent/ECSP003845A/en
Publication of ECSP003845A publication Critical patent/ECSP003845A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula (I) En donde R1 a R7 e Y son tal como se definen en la descripción y las reivindicaciones, y las sales farmacéuticamente aceptables y/o ésteres farmacéuticamente aceptables de los mismos. Los compuestos son útiles para el tratamiento de enfermedades que estén asociadas con las proteasas cisteínicas, tales como la osteoporósis, osteoartritis, artritis reumatoide, metástasis tumoral, glomerulonefritis, arterosclerosis, infarto de miocardio, angina de pecho, angina de pecho inestable, embolia, rotura de placa, ataques isquémicos transitorios, amaurosis fugax, enfermedad oclusiva de las arterias periféricas, restenosis después de angioplastia y colocación de stents, formación de aneurismo aórtico, inflamación, enfermedades autoinmunes, malaria, citopatía del tejido del fondo ocular, y enfermedades respiratorias.The present invention relates to compounds of formula (I) wherein R1 to R7 and Y are as defined in the description and claims, and pharmaceutically acceptable salts and / or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment of diseases that are associated with cysteine proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis, atherosclerosis, myocardial infarction, angina pectoris, unstable angina pectoris, embolism, rupture of plaque, transient ischemic attacks, fugax amaurosis, peripheral artery occlusive disease, restenosis after angioplasty and stenting, formation of aortic aneurism, inflammation, autoimmune diseases, malaria, ocular fundus cytopathy, and respiratory diseases.

ECSP003845 2000-12-21 2000-12-21 NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS ECSP003845A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003845 ECSP003845A (en) 2000-12-21 2000-12-21 NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003845 ECSP003845A (en) 2000-12-21 2000-12-21 NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP003845A true ECSP003845A (en) 2001-07-27

Family

ID=42041395

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003845 ECSP003845A (en) 2000-12-21 2000-12-21 NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP003845A (en)

Similar Documents

Publication Publication Date Title
UY26504A1 (en) "NITRILE DERIVED AS CATEPSINE K INHIBITORS"
ECSP024383A (en) BETA-AMINO ACIDS NITRILE DERIVATIVES
UY27561A1 (en) HETEROARIL NITRILOS
BG104631A (en) Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
PA8544901A1 (en) OXAZOL DERIVATIVES
PE115399A1 (en) ACICLIC METALOPROTEASE INHIBITORS
AR077267A1 (en) SELECTED INHIBITING NITROGEN DERIVATIVES OF PI3K, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF INFLAMMATORY AND / OR AUTOIMMUNE DISEASES.
UY26782A1 (en) DERIVATIVES OF BENZOTIAZOLE
ES2213732T3 (en) NEW ESTERS DERIVED FROM SUBSTITUTED FENIL-CICLOHEXIL COMPOUNDS.
DE60235019D1 (en) BENZOTHIAZEPINE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDEMIA
BR9814484A (en) "aspartyl protease inhibitor prodrugs"
CO5601002A2 (en) ACC INHIBITORS
WO2008123800A3 (en) Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles
CO5570668A2 (en) HIMBACINE SUBSTITUTED TRICYCLES DERIVATIVES THAT ARE ANTAGONISTS OF THE THROMBINE RECEPTOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PE20070135A1 (en) HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ASPARTILE PROTEASES
AR035804A1 (en) NOVELTY INHIBITORS OF TYROSINE KINASE
ECSP024360A (en) PHENYLGLYCIN DERIVATIVES
UY27774A1 (en) METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
PE20020884A1 (en) 4-FLUORO-N-INDAN-2-IL-BENZAMIDE AND ITS USE AS A PHARMACEUTICAL PRODUCT
AR061583A1 (en) ACIDS 6- (BENCILO REPLACED WITH HETEROCICLIL) -4-CARBOXYL OXYQUINOLIN, HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES AS ANTI-HIV AGENTS.
DK1513519T3 (en) Use of substituted cyanopyrrolidines for the treatment of hyperlipidemia
AR057414A1 (en) PROSTAGLANDINA DERIVATIVES
ECSP003845A (en) NITRILE DERIVATIVES AS CATEPSIN K INHIBITORS
DE602006015291D1 (en) HIV-INHIBITED 2- (4-CYANOPHENYL) -6-HYDROXYLAMINOPYRIMIDINE
UY27959A1 (en) NEW AGARIST PPAR ALFA AND PPAR RANGE